Reply to Alexander Yang, Vincent L. Cannataro, Jeffrey P. Townsend's Letter to the Editor, re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as, a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer. Eur Urol 2019, 76:9-13

Affiliations

• ¹ Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France; Paris-Sud University, Paris-Saclay University, Paris, France; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
• ² Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France; Paris-Sud University, Paris-Saclay University, Paris, France; Department of Urology, Zhongnan Hospital, Wuhan University, Wuhan, China.
• ³ Institut Curie, CNRS, UMR3244, PSL Research University, Paris, France; Sorbonne Université, Paris, France.
• ⁴ Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
• ⁵ Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France.
• ⁶ Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁷ Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France. Electronic address: isabelle.bernard-pierrot@curie.fr.